Flagship Ventures Fund IV General Partner LLC Insider Trading $MRNA Moderna, Inc.
Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is 10% Owner in Seres Therapeutics, Inc. ($MCRB) and 10% Owner in Axcella Health Inc. ($AXLA) and Director in Moderna, Inc. ($MRNA) and 10% Owner in Evelo Biosciences, Inc. ($EVLO) and 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and Director in Rubius Therapeutics, Inc. ($RUBY) and 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and Director in Kaleido Biosciences, Inc. ($KLDO) and 10% Owner in TransMedics Group, Inc. ($TMDX).
Flagship Ventures Fund IV General Partner LLC in Moderna, Inc.
Trading Symbol: MRNAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Flagship Ventures Fund IV General Partner LLC: Director
Holdings: 14,435,589 shares
Latest Transaction: Aug 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC in Moderna, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 19 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 2,053,049 | 0 | 0 | 2.1 M to 0 (-100.00 %) |
Aug 19 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,449,190 | 0 | 4,971,576 | 6.4 M to 5 M (-22.57 %) |
Aug 19 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 7,550,810 | 0 | 14,435,589 | 22 M to 14.4 M (-34.34 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 10,746 | 754,113 | 6,420,766 | 6.4 M to 6.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 69,254 | 4,809,448 | 6,431,512 | 6.5 M to 6.4 M (-1.07 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.18 | 56,406 | 3,958,353 | 21,986,399 | 22 M to 22 M (-0.26 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 69.45 | 363,594 | 25,250,331 | 22,042,805 | 22.4 M to 22 M (-1.62 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 367 | 26,584 | 6,500,766 | 6.5 M to 6.5 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 2,551 | 182,433 | 6,501,133 | 6.5 M to 6.5 M (-0.04 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 3,900 | 274,780 | 6,503,684 | 6.5 M to 6.5 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 7,443 | 512,185 | 6,507,584 | 6.5 M to 6.5 M (-0.11 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 23,199 | 1,557,822 | 6,515,027 | 6.5 M to 6.5 M (-0.35 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 42,540 | 2,797,690 | 6,538,226 | 6.6 M to 6.5 M (-0.65 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 1,933 | 140,017 | 22,406,399 | 22.4 M to 22.4 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 13,408 | 958,861 | 22,408,332 | 22.4 M to 22.4 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 20,492 | 1,443,793 | 22,421,740 | 22.4 M to 22.4 M (-0.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 39,082 | 2,689,404 | 22,442,232 | 22.5 M to 22.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 121,771 | 8,176,971 | 22,481,314 | 22.6 M to 22.5 M (-0.54 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 223,314 | 14,686,491 | 22,603,085 | 22.8 M to 22.6 M (-0.98 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 2,281,179 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,610,000 | 0 | 6,580,766 | 8.2 M to 6.6 M (-19.66 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 8,390,000 | 0 | 22,826,399 | 31.2 M to 22.8 M (-26.88 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 38,366 | 715,710 | 8,190,766 | 8.2 M to 8.2 M (-0.47 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.65 | 199,935 | 3,729,747 | 31,216,399 | 31.4 M to 31.2 M (-0.64 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 4,092 | 77,579 | 8,229,132 | 8.2 M to 8.2 M (-0.05 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.96 | 21,325 | 404,292 | 31,416,334 | 31.4 M to 31.4 M (-0.07 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 27,714 | 526,408 | 8,233,224 | 8.3 M to 8.2 M (-0.34 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 18.99 | 144,423 | 2,743,199 | 31,437,659 | 31.6 M to 31.4 M (-0.46 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,735,720 | 0 | 0 | 1.7 M to 0 (-100.00 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,207,658 | 0 | 8,260,938 | 9.5 M to 8.3 M (-12.75 %) |
Dec 11 2019 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 6,292,342 | 0 | 31,582,082 | 37.9 M to 31.6 M (-16.61 %) |
Page: 1